Integra LifeSciences Continues to Make Progress on Its ESG Strategy
Integra LifeSciences (NASDAQ: IART) has released its third Environmental, Social and Governance (ESG) report, highlighting the company's 2023 performance and ongoing efforts in line with its ESG strategy. Key achievements include:
Environmental: Recalculated Scope 1, 2, and 3 emissions and partnered with external consultants to identify energy reduction opportunities.
Social: Enhanced diversity and inclusion efforts by adding a new employee resource group and supporting diverse college students and graduates.
Governance: Revised Code of Conduct and strengthened anti-bribery and corruption programs.
The report aligns with the Global Reporting Index and Sustainability Accounting Standards Board Index, demonstrating Integra's commitment to creating healthier people, workplaces, and world.
Integra LifeSciences (NASDAQ: IART) ha pubblicato il suo terzo rapporto su Ambiente, Sociale e Governance (ESG), evidenziando le prestazioni dell'azienda nel 2023 e gli sforzi continui in linea con la sua strategia ESG. Tra i principali risultati si annoverano:
Ambientale: Ricalcolo delle emissioni Scope 1, 2 e 3 e collaborazione con consulenti esterni per identificare opportunità di riduzione dell'energia.
Sociale: Miglioramento degli sforzi per la diversità e l'inclusione attraverso la creazione di un nuovo gruppo di risorse per i dipendenti e il supporto a studenti universitari e neolaureati provenienti da background diversi.
Governance: Revisione del Codice di Condotta e rafforzamento dei programmi contro la corruzione e la concussione.
Il rapporto è in linea con l'Indice di rendicontazione globale e l'Indice degli standard contabili per la sostenibilità, dimostrando l'impegno di Integra nel creare persone, luoghi di lavoro e un mondo più sani.
Integra LifeSciences (NASDAQ: IART) ha publicado su tercer informe sobre Medio Ambiente, Social y Gobernanza (ESG), destacando el rendimiento de la empresa en 2023 y sus esfuerzos continuos en línea con su estrategia ESG. Los logros clave incluyen:
Medio Ambiente: Cálculo de las emisiones Scope 1, 2 y 3 y colaboración con consultores externos para identificar oportunidades de reducción de energía.
Social: Mejora de los esfuerzos de diversidad e inclusión mediante la adición de un nuevo grupo de recursos para empleados y apoyo a estudiantes universitarios y graduados diversos.
Gobernanza: Revisión del Código de Conducta y fortalecimiento de los programas contra el soborno y la corrupción.
El informe se alinea con el Índice Global de Reporte y el Índice de Normas de Contabilidad de Sostenibilidad, demostrando el compromiso de Integra para crear personas, lugares de trabajo y un mundo más saludables.
Integra LifeSciences (NASDAQ: IART)는 회사의 2023년 성과와 ESG 전략에 따른 지속적인 노력을 강조한 세 번째 환경, 사회 및 거버넌스(ESG) 보고서를 발표했습니다. 주요 성과는 다음과 같습니다:
환경: Scope 1, 2 및 3 배출량을 재계산하고 에너지 절약 기회를 발견하기 위해 외부 컨설턴트와 협력했습니다.
사회: 새로운 직원 자원 그룹을 추가하고 다양한 대학생 및 졸업생을 지원하여 다양성과 포함 노력을 확대했습니다.
거버넌스: 행동 강령을 수정하고 뇌물 공여 및 부패 방지 프로그램을 강화했습니다.
이 보고서는 글로벌 보고 지수 및 지속 가능성 회계 기준 위원회 지수와 일치하여 Integra가 더 건강한 사람들, 작업장 및 세상을 만드는 데 대한 의지를 보여줍니다.
Integra LifeSciences (NASDAQ: IART) a publié son troisième rapport sur l'Environnement, le Social et la Gouvernance (ESG), mettant en avant les performances de l'entreprise en 2023 et ses efforts continus dans le cadre de sa stratégie ESG. Les principales réalisations comprennent :
Environnemental : Recalcul des émissions Scope 1, 2 et 3 et partenariat avec des consultants externes pour identifier des opportunités de réduction de l'énergie.
Social : Amélioration des efforts de diversité et d'inclusion en ajoutant un nouveau groupe de ressources pour les employés et en soutenant des étudiants et diplômés issus de divers horizons.
Gouvernance : Révision du Code de conduite et renforcement des programmes de lutte contre la corruption et la fraude.
Le rapport est aligné sur l'Indice de Reporting Mondial et l'Indice des Normes Comptables de Durabilité, démontrant l'engagement d'Integra à créer des personnes, des lieux de travail et un monde plus sains.
Integra LifeSciences (NASDAQ: IART) hat ihren dritten Bericht über Umwelt, Soziales und Governance (ESG) veröffentlicht, der die Unternehmensleistung im Jahr 2023 und die laufenden Bemühungen im Einklang mit ihrer ESG-Strategie hervorhebt. Zu den wichtigsten Errungenschaften gehören:
Umwelt: Neuberechnung der Scope-1-, 2- und 3-Emissionen und Zusammenarbeit mit externen Beratern zur Identifizierung von Energiespareinrichtungen.
Sozial: Verbesserung der Diversitäts- und Inklusionsbemühungen durch die Bildung einer neuen Mitarbeiterressourcengruppe und die Unterstützung vielfältiger Hochschulstudenten und Absolventen.
Governance: Überarbeitung des Verhaltenskodex und Stärkung der Programme zur Bekämpfung von Bestechung und Korruption.
Der Bericht stimmt mit dem Global Reporting Index und dem Sustainability Accounting Standards Board Index überein und zeigt das Engagement von Integra, gesündere Menschen, Arbeitsplätze und eine bessere Welt zu schaffen.
- None.
- None.
The company published its third ESG report, underscoring its values and commitment to restoring lives
PRINCETON, N.J., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Company (NASDAQ: IART), a leading global medical technology company, today issued its latest Environmental, Social and Governance (ESG) report. The report highlights the company’s 2023 ESG performance and ongoing efforts against the ESG strategy and roadmap established three years ago.
“Innovating treatment pathways to advance patient outcomes and set new standards of care is work that matters to our Integra colleagues around the world and is what drives us each and every day,” said Jan De Witte, president and chief executive officer, Integra LifeSciences. “We are pleased with the advances we have made to meet our ESG commitments and ambitions as we play our part to create healthier people, a healthier workplace and a healthier world.”
Integra’s ESG report includes the past year’s highlights in key areas:
- Environmental – Recalculated Scope 1, 2 and 3 emissions and partnered with an external consultant to conduct energy assessments at highest energy usage locations to identify energy reduction opportunities and improve greenhouse gas footprint
- Social – Bolstered diversity and inclusion efforts by adding a new employee resource group and furthering our focus on early-in-career talent by providing support and hands-on experience to diverse college students and graduates
- Governance – Revised Code of Conduct and continued to strengthen anti-bribery and corruption program through ongoing training curriculums and programs
Integra prepared its ESG report in alignment with external guidelines and measurement frameworks, including the Global Reporting Index and the Sustainability Accounting Standards Board Index.
Read the full report here.
About Integra
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit investor.integralife.com.
Contacts:
Investors:
Chris Ward
(609) 936-2322
chris.ward@integralife.com
Media:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
FAQ
What are the key highlights of Integra LifeSciences' 2023 ESG report?
How has Integra LifeSciences (IART) improved its environmental performance in 2023?
What social initiatives did Integra LifeSciences (IART) implement in 2023?
How has Integra LifeSciences (IART) enhanced its governance practices in the latest ESG report?
Which external guidelines did Integra LifeSciences (IART) use for its 2023 ESG report?
